Patents by Inventor Delphine Nombret

Delphine Nombret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890383
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Grant
    Filed: November 1, 2022
    Date of Patent: February 6, 2024
    Assignee: Capsugel Belgium NV
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne
  • Publication number: 20230090812
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Application
    Filed: November 1, 2022
    Publication date: March 23, 2023
    Applicant: Capsugel Belgium NV
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne
  • Patent number: 11517535
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: December 6, 2022
    Assignee: Capsugel Belgium NV
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne
  • Publication number: 20210052505
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Application
    Filed: May 14, 2019
    Publication date: February 25, 2021
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne